Invivyd, Inc. (IVVD) Form 8-K Summary
Business Context and Reporting Period
Invivyd, Inc., a Delaware corporation, filed this Current Report on Form 8-K on December 27, 2024. The filing addresses a regulatory notice received from the Nasdaq Stock Market LLC regarding the continued listing status of the Company's common stock.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only financial metric disclosed is the stock price performance triggering the regulatory notice.
- Stock Symbol: IVVD
- Exchange: The Nasdaq Global Market
- Triggering Event: The closing bid price of the Common Stock remained below $1.00 per share for 30 consecutive business days prior to December 27, 2024.
Material Changes and Regulatory Status
The Company received a deficiency letter from Nasdaq citing non-compliance with Listing Rule 5450(a)(1) (Minimum Bid Price Requirement). The stock continues to trade on The Nasdaq Global Market at this time, but the Company is now in a compliance period.
- Compliance Deadline: June 25, 2025 (180 calendar days from the notice date).
- Requirement to Regain Compliance: The closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days within the compliance period.
- Consequences of Non-Compliance: If the Company fails to regain compliance by the deadline, it may be eligible for a second 180-day period only if it transfers to The Nasdaq Capital Market and meets specific market value requirements. Failure to cure the deficiency ultimately results in delisting.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the closing bid price and will consider implementing available options to resolve the deficiency. However, the Company explicitly states there can be no assurance that it will be able to regain compliance or that Nasdaq will grant any extensions or relief.
Risks and Contingencies:
- Failure to regain compliance could lead to delisting.
- Any appeal of a delisting determination to a Nasdaq Hearings Panel is not guaranteed to be successful.
- Forward-looking statements regarding the ability to cure the deficiency are subject to significant risks and uncertainties.
Key Facts for Investor Verification
- Verify the current closing bid price of IVVD to assess proximity to the $1.00 threshold.
- Monitor the Company's announcements regarding potential reverse stock splits or other capital structure changes intended to address the bid price deficiency.
- Review the Company's most recent Form 10-K and 10-Q filings for liquidity and cash position details, as this 8-K does not provide financial health metrics.
- Track the June 25, 2025 deadline for the initial compliance period.